Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death worldwide. This high mortality rate is due to the disease’s lack of symptoms, resulting in a late diagnosis. Biomarkers and treatment options for pancreatic cancer are also limited. In order to overcome this,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Shannon R., Walsh, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281628/
https://www.ncbi.nlm.nih.gov/pubmed/32423157
http://dx.doi.org/10.3390/cancers12051233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281628/
https://www.ncbi.nlm.nih.gov/pubmed/32423157
http://dx.doi.org/10.3390/cancers12051233

Ejemplares similares